Accelerated partial breast irradiation: An updated report from the American Brachytherapy Society

Brachytherapy

Volumn 1, Issue 4, 2002, Pages 184-190

  Arthur, Douglas W ^a   Vicini, Frank A ^b   Kuske, Robert R ^c   Wazer, David E ^d   Nag, Subir ^e  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Brachytherapy; Breast neoplasm; Interstitial; Radiotherapy

Indexed keywords

BRACHYTHERAPY; BREAST CARCINOMA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONSERVATIVE TREATMENT; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; PARTIAL MASTECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; REVIEW; SEGMENTAL MASTECTOMY; UNITED STATES; VALIDATION PROCESS;

EID: 0242383930     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1538-4721(02)00099-5     Document Type: Article

References (58)

1. Nag S., Kuske R.R., Vicini F.et al. The American Brachytherapy Society Recommendations for Brachytherapy for Carcinoma of the Breast. Oncology. 15:2001;195-207.
2. Fischer B., Anderson S., Bryant J.et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 347:2002;1233-1241.
3. Veronesi U., Cascinelli N., Mariani L.et al. Twenty-year follow-up of randomized study comparing breast-conserving surgery with radical (Halstead) mastectomy for early breast cancer. N Engl J Med. 347:2002;1227-1232.
4. Vrieling C., Collete L., Fourquet A.et al. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. Radiother Oncol. 55:2000;219-232.
5. Vrieling C., Collete L., Fourquet A.et al. The influence of the boost in breast-conserving therapy on cosmetic outcome in the ORTC "boost versus no boost" trial. Int J Radiat Oncol Biol Phys. 45:1999;677-685.
6. Wazer D.E., Dipetrillo T., Schmidt-Ullrich R.et al. Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early stage breast carcinoma. J Clin Oncol. 10:1992;356-363.
7. Schmidt-Ullrich R.K., Wazer D.E., DiPetrillo T.et al. Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates. A case for aggressive therapy to the tumor bearing quadrant Int J Radiat Oncol Biol Phys. 27:1993;545-552.
8. Athas W.F., Adams-Cameron M., Hunt W.C.et al. Travel distance to radiation therapy and receipt of radiotherapy after breast-conserving surgery. J Natl Cancer Inst. 92:2000;269-271.
9. Hevert-Croteau N., Brisson J., Latreille J.et al. Compliance with consensus recommendation for the treatment of early stage breast carcinoma in elderly women. Cancer. 85:1999;1104-1113.
10. Du X., Freeman J.L., Freeman D.H.et al. Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1985. J Gerontol A Biol Sci Med Sci. 54:1999;474-478.
11. Nattinger A.B., Hoffmann R.G., Kneusel R.T.et al. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 356:2000;1148-1153.
12. National Institutes of Health Consensus Statement. treatment of early-stage breast cancer:1990;NIH, Bethesda, MD.
13. Fischer B., Bryant J., Dignam J.J.et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 20:2002;4141-4149.
14. Liljegren G., Holmberg L., Bergh J.et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer. a randomized trial J Clin Oncol. 17:1999;2326-2333.
15. Holland R., Veling S.H.J., Mravunac M.et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery Cancer. 56:1985;979-990.
16. Faverly D., Holland R., Burgers L. An original stereomicroscopic analysis of the mammary glandular tree. Virchows Archiv A Pathol Anat. 421:1992;115-119.
17. Faverly D., Burgers L., Bult P.et al. Three dimensional imaging of mammary ductal carcinoma in situ. clinical implications Sem Diagn Pathol. 11:1994;193-198.
18. Imamura H., Haga S., Shimizu T.et al. Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat. 62:2000;177-184.
19. Ohtake T., Abe R., Kimijima I.et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Cancer. 76:1995;32-45.
20. Fisher B., Anderson S. Conservative Surgery for the management of invasive and noninvasive carcinoma of the breast. NSABP trials World J Surg. 18:1994;63-69.
21. Fischer E.R., Dignam J., Tan-Chiu E.et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17. Cancer. 86:1999;429-438.
22. Holli K., Saaristo R., Isola J.et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features. results of a randomized study Br J Cancer. 84:2001;164-169.
23. Veronesi U., Marubini E., Mariani L.et al. Radiotherapy after breast-conserving surgery in small breast carcinoma. long-term results of a randomized trial Ann Oncol. 12:2001;997-1003.
24. Clark R.M., McCulloch P.B., Levine M.N.et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 84:1992;683-689.
25. Uppsala-Oreboro Breast Cancer Study Group Sector resection with or without postoperative radiotherapy for stage I breast cancer. a randomized trial J Natl Cancer Inst. 82:1990;277-282.
26. Clark R.M., Whelan T., Levine M.et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. an update. Ontario Clinical Oncology Group J Natl Cancer Inst. 88:1996;1659-1664.
27. Liljegren G., Holmberg L., Adami H.O.et al. Uppsala-Oreboro Breast Cancer Study Group. sector resection with or without post-operative radiotherapy for stage I breast cancer: five-year results of a randomized trial J Natl Cancer Inst. 86:1994;717-722.
28. Smith T.E., Daesung L., Turner B.C.et al. True recurrence vs. new primary ipsilateral breast tumor relapse. an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management Int J Radiat Oncol Biol Phys. 48:2000;1281-1289.
29. Obedian E., Fischer D.B., Haffty B.G. Second malignancies after treatment of early-stage breast cancer. lumpectomy and radiation therapy versus mastectomy J Clin Oncol. 18:2000;2406-2412.
30. Morrow M. Rational local therapy for breast cancer. N Engl J Med. 347:2002;1270-1271.
31. is,1,2 breast cancer. Am J Surg. 80:2000;299-304.
32. Vicini F.A., Baglan K.L., Kestin L.L.et al. Accelerated treatment of breast cancer. J Clin Oncol. 19:2001;1993-2001.
33. Chen P.Y., Vicini F., Baglan K.et al. Accelerated partial breast irradiation via interstitial brachytherapy as the sole radiation modality for treatment of early-stage breast cancer (Abstr.). Int J Radiat Oncol Biol Phys. 54(Suppl.):2002;88.
34. Krishnan L., Jewell W.R., Tawfik O.W.et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 7:2001;91-96.
35. Polgar C., Sulyok Z., Fodor J.et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer. five-year results of a phase I-II study and initial findings of a randomized phase III trial J Surg Oncol. 80:2002;121-128.
36. Cionini L., Pacini P., Marzano S.et al. Exclusive brachytherapy after conservative surgery in cancer of the breast (Abstr.). Lyon Chir. 89:1993;128.
37. Wazer D.E., Berle L., Graham R.et al. Preliminary results of a phase I/ II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 53:2002;889-897.
38. Arthur D.W., Warwicke L.A., Arnfield M.R.et al. Recall reactions and early breast fibrosis with he use of adriamycin following lumpectomy and brachytherapy only for early stage breast cancer. Int J Radiat Oncol Biol Phys. 51(Supp 1):2001;284.
39. Lawenda B.D., Taghian A.G., Kachnic L.A.et al. A dose-volume analusis of radiation therapy for T1N0 invasive breasst cancer treated by local excision and partial breast irradiation by low-dose rate interstitial implant (Abstr.). Int J Radiat Oncol Biol Phys. 54(Suppl):2002;162.
40. Kuske R.R., Bolton J.S. A phase I/II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma. 1995;Radiation Therapy Oncology Group; Philadelphia, PA. Publication no. 1055.
41. Kuske R.R., Winter K., Arthur D.et al. A phase I/II trial of brachytherapy alone following lumpectomy for selct breast cancer. toxicity analysis of radiation therapy oncology group 95-17 (Abstr.) Int J Radiat Oncol Biol Phys. 54(Suppl):2002;87.
42. Hanson W., Martin B., Kuske R.et al. Dose specification and quality assurance of RTOG 95-17, a cooperative group study of 192Ir breast implants as sole therapy (Abstr.). Med Phys. 28:2001;1297.
43. Fentimen I.S., Poole C., Tong D.et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 32A:1996;608-611.
44. Magee B., Swindell R., Harris M.et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy. results from a randomized trial Radiother Oncol. 39:1996;223-227.
45. American Brachytherapy Society's School of Breast Brachytherapy, New Orleans, LA, January, 2002.
46. Kuske R.R. Breast brachytherapy. Hematol Oncol Clin North Am. 13:1999;543-558.
47. Polgar C., Fodor J., Major T.et al. Radiotherapy confined to the tumor bed following breast conserving surgery. Strahlenther Onkol. 11:2002;1-10.
48. Keisch M.E., Kuske R.R., Toonkel L.M.et al. A prospective phase I trial of an implantable balloon applicator for breast brachytherapy. Radiology. 221(Suppl):2001;236.
49. Keisch M., Vicini F., Kuske R.R.et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Physi. 55:2003;289-293.
50. Edmundson G.K., Vicini F.A., Chen P.Y.et al. Dosimetric characteristics of the mammosite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 52:2002;1132-1139.
51. Vaidya J.S., Tobias J.S., Baum M.et al. Targeted intra-operative radiotherapy (Targit) for breast cancer. a randomized trial Radiology. 221(suppl):2001;234.
52. Vaidya J.S., Baum M., Tobias J.S.et al. Targeted intra-operative radiotherapy (Targit). An innovative method of treatment for early breast cancer Ann Oncol. 12:2001;1075-1080.
53. Veronesi U., Orecchia R., Luini A.et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Euro J Cancer. 37:2001;2178-2183.
54. Formenti S.C., Rosenstein B., Skinner K.A.et al. T1 stage breast cancer. adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients-pilot feasibility study Radiology. 222:2002;171-178.
55. Baglan K.L., Sharpe M.B., Jaffray D.et al. Accelerated partial breast irradiation using 3D-conformal radiation therapy (3D-CRT) (Abstr.). Int J Radiat Oncol Biol Phys. 55:2002;302-311.
56. Vicini FA, Private communication, 2002.
57. Overgaard M., Hansen P.S., Overgaard J.et al. The Danish Breast Cancer Cooperative Group 82b Trial. New Eng J Med. 337:1997;949-955.
58. Ragaz J., Jackson S.M., Le N.et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. New Eng J Med. 337:1997;956-962.